title: Experiences with interferon-beta-1b treatment in MS after three year follow-up.
authors.forename: Krisztina
authors.initials: K
authors.lastname: Bencsik
authors.forename: Cecilia
authors.initials: C
authors.lastname: Rajda
authors.forename: Judit
authors.initials: J
authors.lastname: Füvesi
authors.forename: Tamás
authors.initials: T
authors.lastname: Járdánházy
authors.forename: Margit
authors.initials: M
authors.lastname: Török
authors.forename: László
authors.initials: L
authors.lastname: Vécsei
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D017327:Clinical Trials, Phase IV as Topic; D005500:Follow-Up Studies; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a